← Back
Data updated: Mar 10, 2026
HUMAN GENOME SCIENCES INC.
Immunology
HUMAN GENOME SCIENCES INC. is a biotechnology company focused on Immunology. Key products include RAXIBACUMAB.
2011
Since
2
Drugs
-
Trials
4
Approved (2yr)
Recent Activity
BENLYSTA 2025-06-20
Efficacy
BENLYSTA 2025-06-20
Labeling
BENLYSTA 2024-05-16
Efficacy
BENLYSTA 2024-05-16
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2011-03-09
- Latest
- 2025-06-20
- Applications
- 2